MS Roth
- Hematology top 2%
- Chronic Myeloid Leukemia Treatments 8
- Acute Myeloid Leukemia Research 3
- Blood groups and transfusion 2
- Hematopoietic Stem Cell Transplantation 2
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research 3
-
- T-cell and B-cell Immunology 2
- Transplantation top 10%
-
- Eosinophilic Disorders and Syndromes 5
-
- Blood transfusion and management 2
- Co-authors
- JH AntinDavid GinsburgWilliam R. DrobyskiSusanne KoetheRC AshJL GottschallPatrick McFaddenPeter van Tuinen
- Cited by
- HematologyGeneticsImmunology
- Journals
- Blood (9 papers)PubMed (5 papers)
- Partner nations
- United StatesPoland
In The Last Decade
MS Roth
14 papers receiving 701 citations
Peers
Comparison fields: 5 of 50
- Hematology 584
- Genetics 189
- Immunology 196
- Transplantation 19
- Oncology 142
Countries citing papers authored by MS Roth
This map shows the geographic impact of MS Roth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by MS Roth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites MS Roth more than expected).
Fields of papers citing papers by MS Roth
This network shows the impact of papers produced by MS Roth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by MS Roth. The network helps show where MS Roth may publish in the future.
Co-authorship network
The 16 scholars most cited alongside MS Roth, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Assessing the economic value of antihypertensive medications. | 1998 | 3 |
| 2 | 1993 | 277 | |
| 3 | 1993 | 11 | |
| 4 | 1992 | 4 | |
| 5 | 1992 | 4 | |
| 6 | 1992 | 67 | |
| 7 | Molecular remission occurring after donor leukocyte infusions for the treatment of relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation. | 1992 | 39 |
| 8 | 1992 | 119 | |
| 9 | Application of the polymerase chain reaction for detection of minimal residual disease of hematologic malignancies. | 1991 | 2 |
| 10 | 1989 | 5 | |
| 11 | 1989 | 153 | |
| 12 | 1988 | 6 | |
| 13 | Regressing atypical histiocytosis: a review and critical appraisal. | 1987 | 29 |
| 14 | Large endometrioma occurring in an adolescent. | 1977 | 2 |
About MS Roth
MS Roth is a scholar working on Hematology, Biochemistry, Rheumatology, Management of Technology and Innovation and Genetics, having authored 14 papers that have together received 721 indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (8 papers), Eosinophilic Disorders and Syndromes (5 papers), Acute Myeloid Leukemia Research (3 papers), Chronic Lymphocytic Leukemia Research (3 papers), Blood transfusion and management (2 papers), Blood groups and transfusion (2 papers), Hematopoietic Stem Cell Transplantation (2 papers) and T-cell and B-cell Immunology (2 papers). The work is most often cited by research in Hematology (584 citations), Genetics (189 citations), Immunology (196 citations), Transplantation (19 citations) and Oncology (142 citations). MS Roth has collaborated with scholars based in United States and Poland. Frequent co-authors include JH Antin, David Ginsburg, William R. Drobyski, Susanne Koethe, RC Ash, JL Gottschall, Patrick McFadden, Peter van Tuinen, CA Keever and Gerald A. Hanson. Their work appears in journals such as Blood and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.